"Xiangsheng Technology" has recently proudly declared the successful closure of two back-to-back Angel+ financing rounds, raising tens of millions of yuan. These rounds were co-led by the industry-focused Corporate Venture Capital (CVC) entity Meilijingjie Capital, along with Yida Capital and Nachuan Capital. Additional investors included Inno Angel Fund, Suzhou Science and Technology Innovation Investment, Suzhou Angel Mother Fund, and Su Gaoxin Science and Technology Innovation Angel Fund, among other contributors. The proceeds from these financing rounds will be strategically allocated towards the establishment of an AI-driven technology platform, the advancement of product development, the expansion of production lines, and the construction of a state-of-the-art intelligent factory.

Established in January 2024, "Xiangsheng Technology" leverages the scientific research prowess of institutions such as the Shenzhen Research Institute of Tsinghua University. The company is dedicated to the microfluidic intelligent manufacturing of bio-based and high-performance materials. Its cutting-edge multi-phase microfluidic matrix reaction platform encompasses an AI nanocatalyst module and a fluid simulation calculation and structural design module. These innovative modules are designed to significantly enhance catalyst activity and selectivity, while simultaneously driving down costs. Presently, the company has already operationalized a production line with a capacity of a hundred tons and has ambitious plans to scale it up to a thousand-ton capacity in the coming year.